Warfarin is recommended for patients who typically require anticoagulants. Myocardial infarction (MI), deep vein thrombosis (DVT), and stroke are among the common conditions for which warfarin is prescribed. Many physicians choose warfarin because it allows for direct monitoring. Additionally, it is available in a variety of dosages, allowing healthcare professionals to monitor the international normalized ratio (INR) and guarantee the best possible anticoagulation for their patients. Warfarin inhibits the production of several coagulation factors by acting as a vitamin K antagonist. Warfarin also has the advantage of being reversible with vitamin K. Reports from the literature have shown that warfarin helps some adult individuals with migraine headaches. This case study demonstrates how individuals with migraine headaches may benefit from continuing warfarin therapy, regardless of the medication’s original indication. We describe a case of a 52-year-old man for whom warfarin was crucial in preserving the abortive advantage of migraine headaches and associated visual abnormalities, even though these outcomes are rare and incidental. Based on our case and others documented in the literature, warfarin therapy may be beneficial for individuals with migraine headaches and associated aura. The rapid initiation of warfarin therapy in reducing migraine symptoms is encouraging and deserves further investigation.
